47 related articles for article (PubMed ID: 9629530)
1. Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies.
Thumtecho S; Burlet NJ; Ljungars A; Laustsen AH
J Venom Anim Toxins Incl Trop Dis; 2023; 29():e20230057. PubMed ID: 38116472
[TBL] [Abstract][Full Text] [Related]
2. Hydroxamate-Based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging.
Gona K; Toczek J; Ye Y; Sanzida N; Golbazi A; Boodagh P; Salarian M; Jung JJ; Rajendran S; Kukreja G; Wu TL; Devel L; Sadeghi MM
J Med Chem; 2020 Dec; 63(23):15037-15049. PubMed ID: 33206510
[TBL] [Abstract][Full Text] [Related]
3. Anti-hemorrhagic activity of four Brazilian vegetable species against Bothrops jararaca venom.
Nishijima CM; Rodrigues CM; Silva MA; Lopes-Ferreira M; Vilegas W; Hiruma-Lima CA
Molecules; 2009 Mar; 14(3):1072-80. PubMed ID: 19305361
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis.
Chen KM; Lee HH; Chou HL; Liu JY; Tsai BC; Lai SC
Int J Exp Pathol; 2005 Apr; 86(2):81-9. PubMed ID: 15810979
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
6. Drugs in development: bisphosphonates and metalloproteinase inhibitors.
Catterall JB; Cawston TE
Arthritis Res Ther; 2003; 5(1):12-24. PubMed ID: 12716443
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in arthritic disease.
Murphy G; Knäuper V; Atkinson S; Butler G; English W; Hutton M; Stracke J; Clark I
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S39-49. PubMed ID: 12110122
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors in rheumatic diseases.
Close DR
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii62-7. PubMed ID: 11890658
[TBL] [Abstract][Full Text] [Related]
9. Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils.
Middelhoven PJ; Van Buul JD; Hordijk PL; Roos D
Clin Exp Immunol; 2001 Jul; 125(1):169-75. PubMed ID: 11472441
[TBL] [Abstract][Full Text] [Related]
10. Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.
Chandrasekar N; Jasti S; Alfred-Yung WK; Ali-Osman F; Dinh DH; Olivero WC; Gujrati M; Kyritsis AP; Nicolson GL; Rao JS; Mohanam S
Clin Exp Metastasis; 2000; 18(4):337-42. PubMed ID: 11448065
[TBL] [Abstract][Full Text] [Related]
11. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.
Elliott S; Cawston T
Drugs Aging; 2001; 18(2):87-99. PubMed ID: 11346130
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors: applications in oncology.
Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
[TBL] [Abstract][Full Text] [Related]
13. New leads to cancer, arthritis therapies.
Hagmann M
Science; 1999 Jun; 284(5420):1600-1. PubMed ID: 10383332
[No Abstract] [Full Text] [Related]
14. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent, achiral matrix metalloproteinase inhibitors.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Rydel T; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1998 Sep; 41(19):3568-71. PubMed ID: 9733482
[No Abstract] [Full Text] [Related]
16. Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis.
Shaw T; Nixon JS; Bottomley KM
Expert Opin Investig Drugs; 2000 Jul; 9(7):1469-78. PubMed ID: 11060752
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis.
Bigg HF; Rowan AD
Curr Opin Pharmacol; 2001 Jun; 1(3):314-20. PubMed ID: 11712757
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors in arthritis.
Bottomley KM; Johnson WH; Walter DS
J Enzyme Inhib; 1998 Apr; 13(2):79-101. PubMed ID: 9629530
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
